Clinical Trials on Refractory Malignancies in Belgium
Total 129 results
-
University of LiegeKU Leuven; Amgen; Vrije Universiteit BrusselCompletedHematological MalignanciesBelgium
-
Jules Bordet InstituteUniversité Libre de Bruxelles; Fondation Kisane; Les Amis de l'InstitutUnknownAdults | Hematological Malignancy | Oral Antineoplastic AgentsBelgium
-
Chroma TherapeuticsCompletedLymphoid Malignancies | Hematological DiseaseFrance, Belgium, Netherlands
-
General Hospital GroeningeCompletedOncology | Haematological MalignancyBelgium
-
University of LiegeCompletedHematologic MalignanciesBelgium
-
University Hospital, GhentTerminated
-
University Hospital, GhentCompletedRefractory EpilepsyBelgium
-
Lupin Ltd.CompletedA Study of LNP3794 in Subjects With NRAS/KRAS Mutated Advanced or Metastatic Refractory Solid TumorsNRAS/KRAS Mutated Advanced or Metastatic Refractory Solid TumorsUnited Kingdom, Netherlands, Belgium
-
University of LiegeCompletedHematological MalignanciesBelgium
-
Cliniques universitaires Saint-Luc- Université...Unknown
-
Cliniques universitaires Saint-Luc- Université...RecruitingRefractory EpilepsyBelgium
-
University Hospital, GhentUniversity GhentRecruiting
-
Universitaire Ziekenhuizen KU LeuvenInstitutul Clinic FundeniCompletedHematological MalignancyBelgium, Romania
-
MedImmune LLCCompletedCancer | B-cell MalignanciesUnited States, Italy, Belgium, Canada, Spain
-
University Hospital, GhentResearch Foundation FlandersCompletedEpilepsyBelgium, United States
-
Boston Scientific CorporationCompletedRefractory Pancreatic Duct Strictures | Painful Chronic PancreatitisBelgium
-
University of LiegeKU Leuven; Maastricht University Medical CenterCompletedHematological MalignanciesBelgium, Netherlands
-
EMD SeronoTerminatedHaematological MalignanciesItaly, United States, Switzerland, Belgium, Germany
-
Novartis PharmaceuticalsRecruitingALK Positive MalignanciesGermany, France, Australia, Belgium, Italy, Korea, Republic of, Poland, China, United States, Taiwan, Brazil, Bulgaria, Hong Kong, Japan, Lebanon, Malaysia, Spain, Russian Federation, Colombia, Singapore, Czechia
-
Incyte CorporationRecruitingAdvanced MalignanciesSpain, United States, France, Belgium, Italy
-
Byondis B.V.RecruitingRelapsed / Refractory AML | Relapsed / Refractory MDSSpain, Netherlands, Belgium
-
Janssen Research & Development, LLCCompletedNeoplasms | Neoplasms, Breast | Neoplasms, Ovarian | Advanced or Refractory Solid MalignanciesUnited States, United Kingdom, Spain, Belgium
-
University Hospital, AntwerpRecruitingAcute Myeloid Leukemia, in Relapse | Acute Myeloid Leukemia RefractoryBelgium
-
University Hospital, GhentCompletedHematological Malignancies | CMV InfectionBelgium
-
Novartis PharmaceuticalsActive, not recruitingAdvanced Malignancies That Harbor IDHR132 MutationsBelgium, Germany, Spain, Canada, Australia, United States, Netherlands, Singapore
-
University of LiegeTerminatedChronic Graft-Versus-Host Disease | Acute Graft-Versus-Host Disease | Steroid Refractory Graft-Versus-Host DiseaseBelgium
-
Allogene TherapeuticsActive, not recruitingRelapsed/Refractory Large B Cell LymphomaUnited States, Belgium
-
Jules Bordet InstituteRayzeBio, Inc.Not yet recruitingMultiple Myeloma in Relapse | Multiple Myeloma, Refractory | Multiple Myeloma ProgressionBelgium
-
Jules Bordet InstituteMacopharma; Belgian Hematological SocietyRecruitingRefractory Chronic Graft Versus Host Disease (cGVHD)Belgium
-
European Society for Blood and Marrow TransplantationMallinckrodtCompletedSteroid Refractory GVHDSpain, United Kingdom, Sweden, Italy, Israel, France, Denmark, Germany, Poland, Turkey, Romania, Belgium, Greece, Russian Federation
-
Janssen Research & Development, LLCNo longer availableRelapsed or Refractory Multiple MyelomaBelgium, Iceland, Portugal, Slovenia
-
Boston PharmaceuticalsCompletedAdvanced Nonhaematologic MalignanciesUnited States, Korea, Republic of, Taiwan, France, Hong Kong, Belgium, Spain
-
Onconova Therapeutics, Inc.TerminatedMyelodysplastic Syndrome | MDS | Refractory Anemia With Excess Blasts | RAEBUnited States, Spain, Canada, France, Australia, Switzerland, Israel, Japan, Belgium, India, Ireland, United Kingdom, Croatia, Czechia, Poland, Estonia, Germany, Italy, Austria, Hungary, Russian Federation, Sweden
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingRelapsed or Refractory Solid TumorsUnited States, Argentina, Australia, Belgium, Croatia, Czechia, France, Guatemala, Hungary, Israel, Italy, Korea, Republic of, New Zealand, Peru, Russian Federation, Serbia, South Africa, Spain, Sweden, Turkey
-
Celyad Oncology SAActive, not recruitingRelapse/Refractory Multiple MyelomaBelgium, United States
-
MedtronicNeuroCompletedRefractory EpilepsyBelgium, Sweden, Austria, United Kingdom, Poland, Germany, Portugal, Canada, Finland, Hungary, Italy, Netherlands, Russian Federation
-
Neovasc Inc.CompletedRefractory AnginaUnited Kingdom, Canada, Belgium, Denmark, Netherlands, Sweden
-
Menarini GroupTerminatedMetastatic Solid Tumors | Relapsed/Refractory Non-Hodgkin LymphomaItaly, Spain, Belgium, United Kingdom
-
DeuterOncologyRecruitingAdult Solid Tumor | Lung Cancer | Advanced Solid Tumor | Non-small Cell Lung Cancer | Non-small Cell Carcinoma | Refractory Tumor | Hereditary Renal Papillary CancerFrance, Belgium, Netherlands
-
Incyte CorporationRecruitingB-Cell MalignanciesUnited States, Spain, Belgium, Japan, Italy, France, United Kingdom, Israel, Turkey, Norway, Korea, Republic of, Czechia, Sweden, Austria, Poland, Hungary, Denmark
-
SanofiCompletedHematological MalignancyGreece, Spain, Peru, Israel, United States, Argentina, Belgium, Brazil, Chile, Finland, France, Italy, Mexico, Russian Federation, Turkey, Ukraine, United Kingdom
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedLymphoma | Refractory or Relapsed Solid TumorsKorea, Republic of, United States, Canada, Belgium, Denmark
-
Incyte CorporationTerminatedSolid Tumors and Hematologic MalignancyUnited States, Netherlands, Belgium
-
Kiadis PharmaCompletedAcute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Myelodysplastic SyndromeCanada, Germany, Belgium, United Kingdom
-
University of LiegeUniversity Hospital, Gasthuisberg; University Hospital, Ghent; University Hospital... and other collaboratorsActive, not recruitingHematological Malignancies | Graft-Versus-Host DiseaseBelgium
-
Athersys, IncCato ResearchCompletedHematologic MalignanciesUnited States, Belgium
-
Marinus PharmaceuticalsWithdrawnRefractory Status EpilepticusSpain, Switzerland, Germany, France, Austria, Italy, Belgium, United Kingdom, Czechia, Croatia, Finland, Lithuania, Israel, Hungary, Poland, Slovakia
-
Kiadis PharmaCompletedAcute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Myelodysplastic SyndromeCanada, Belgium, Germany, Croatia, United Kingdom, Portugal
-
Eisai Inc.CompletedRefractory Partial SeizuresUnited States, France, Germany, Italy, United Kingdom, Belgium, Israel, South Africa, Finland, Russian Federation, Austria, Netherlands, Sweden, India